Table 1 |
||
|
COX-2 selective inhibitors currently marketed in some European, North American, and Latin American countries |
||
|
Generic name |
Proprietary name |
Manufacturer |
|
|
||
|
celecoxib |
Celebrex |
Pharmacia Corporation and Pfizer, Inc |
|
etoricoxib |
Arcoxia |
Merck & Co, Inc |
|
rofecoxib |
Vioxx |
Merck & Co, Inc |
|
valdecoxib |
Bextra |
Pharmacia Corporation and Pfizer, Inc |
|
|
||
|
Hochberg Arthritis Res Ther 2003 5:28 doi:10.1186/ar617 |
||